Also worth noting the results guidance indicates a 50% increase at the low that does not appear to be adequately priced into the market. That is a forward pe of only 6.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025